Krsnaa Diagnostics Approves Issuance of Unlisted NCDs Worth ₹430 Crore
Krsnaa Diagnostics Limited's Board approved the issuance of Unlisted, Secured, Redeemable NCDs worth up to ₹430 crore via private placement. The debentures have a 7-year tenure and will be redeemed in 13 installments starting six months post-allotment. Security will be created over company assets.
The issuance of ₹430 crore in debt is a significant financial event that could impact the company's capital structure and future financial obligations. It is a material amount for the company.
The company announced the approval of debt issuance, which is a standard financial activity. While it provides funding, it also increases leverage. Without specific details on the use of funds or the terms impacting profitability, the sentiment is neutral.
Krsnaa Diagnostics Limited announced today, December 12, 2025, that its Board of Directors has approved the issuance of Unlisted, Secured, Redeemable, and Transferable Non-Convertible Debentures (NCDs) amounting to up to ₹430 crore.
The board meeting, which commenced at 11:30 Hrs. (I.S.T.) and concluded at 12:40 Hrs. (I.S.T.) on December 12, 2025, approved the private placement issuance of these NCDs.
The securities are 43,000 NCDs with a face value of ₹1,00,000 each, aggregating to ₹430 crore. These debentures will have a tenure of seven years from the deemed date of allotment. The company plans to redeem the debentures in thirteen equal installments, commencing six months from the allotment date, with interest and principal payable on a half-yearly basis. A charge will be created over identified assets of the Company as security.
What to do with a filing like this
Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under debt fundraising. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.